Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04486040
Other study ID # GrucaTH
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 14, 2016
Est. completion date March 13, 2020

Study information

Verified date August 2021
Source Prof A Gruca Teaching Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Prospective, randomized trial. 40 patients who underwent revision hip arthroplasty, divided in to two groups with or without drainage. All patients was assessed with ultrasonography on 3rd day after surgery. Bleeding, need for blood transfusion and laboratory test was analyzed after surgery. Patients was assessed with Harris Hips Score and Visual Analog Scale after surgery.


Description:

Inclusion criteria: aseptic loosening, head or insert damage, girdlestone hip. Exclusion criteria: septic loosening, primary or secondary coagulopathy, renal or hepatic failure, thromboembolism in past history. At the end of operation information of drainage was get out from the envelope. On 3rd day all patient get ultrasonography with level of fluid in the joint and hematoma in soft tissue measurement. We analyzed hemoglobin, C-reactive protein, erythrocyte sedimentation rate on 1st and 3rd day after surgery. Visual analog scale was taken on 3rd day after surgery and Harris Hip Score 6 weeks after.


Recruitment information / eligibility

Status Completed
Enrollment 38
Est. completion date March 13, 2020
Est. primary completion date March 13, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - aseptic loosening, - head or insert damage, - girdlestone hip Exclusion Criteria: - septic loosening, - primary or secondary coagulopathy, - renal or hepatic failure, - thromboembolism in past history

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Drainage
Use of the suction drainage after hip revision arthroplasty
No-drainage
Patients without drainage after surgery

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Prof A Gruca Teaching Hospital

Outcome

Type Measure Description Time frame Safety issue
Primary Hematoma size Level of fluid at endoprosthesis neck in ultrasonography 3 days after surgery
Primary Hemoglobin level Hemoglobin level after surgery on 1st and 3rd day after surgery 3 days after surgery
Primary Blood loss Assessing blood loss with use of Gross formula 1 day after surgery
Primary Reinfection Number of patients with infection after surgery performed in the study 2 years after surgery
Secondary Soft tissue hematoma Note hematoma formation in soft tissue after surgery (ultrasonography) 3 days after surgery
Secondary C-reactive protein level Level of C-reactive protein after surgery 3 days after surgery
Secondary Blood transfusion Number of patients who need blood transfusion after surgery 5-14 days after surgery
Secondary Visual Analog Scale Level of pain after surgery, 1- no pain; 10- "the worst pain you ever had" 3 days after surgery
Secondary Harris Hip Score Clinical outcome after surgery, 0-100 points; 100 points the best score 6 weeks after surgery
See also
  Status Clinical Trial Phase
Completed NCT03678168 - A Comparison Between Conventional Throat Packs and Pharyngeal Placement of Tampons in Rhinology Surgeries N/A
Completed NCT04058223 - Comparison of the Short-term Outcomes of Using DST and PPH Staplers in the Treatment of Grade III and IV Hemorrhoids
Completed NCT05669313 - The Effects of Hypothermia and Acidosis on Coagulation During Treatment With Rivaroxaban Measured With ROTEM
Completed NCT04590898 - Peri-device Leakage Closure After LAAO
Active, not recruiting NCT05563883 - Atrial Fibrillation and Cancer: a Nationwide French Cohort Study
Not yet recruiting NCT04537533 - Tranexamic Acid Infusion in Low Dose Versus in High Dose for Reducing Blood Loss in Radical Cystectomy Operations Phase 4
Withdrawn NCT02851940 - Pain and Bleeding Following Hypertonic Saline Sclerotherapy Compared to Brand Ligation for Symptomatic Hemorrhoids N/A
Completed NCT02722720 - Carotid Arteries Stenting Complications: Transradial Approach Versus Transfemoral N/A
Recruiting NCT02279186 - Effectiveness of Intravenous Tranexamic Acid in Reducing Blood Loss During and After Cesarean Section Phase 4
Active, not recruiting NCT02244853 - Heart Rate and Cardiovascular Diseases Prognosis in People With Stable Coronary Artery Disease N/A
Completed NCT02245854 - Efficacy and Safety of a New Polypectomy Snare for Cold-polypectomy for Small Colorectal Polyps N/A
Completed NCT02980497 - Antiplaque/Antigingivitis Efficacy of Essential Oil Mouthrinses in Six-Month Study N/A
Completed NCT02092415 - Assessment of Limb Perfusion During Junctional Tourniquet N/A
Not yet recruiting NCT01438736 - Is Cerazette Use Before Nexplanon Insertion Predictive for Bleeding Pattern? Phase 4
Completed NCT00515541 - Lovaza's Effect on the Activation of Platelets Phase 2
Completed NCT00143715 - Oral Vitamin K for Warfarin Associated Coagulopathy Phase 3
Terminated NCT03954314 - DEPOSITION - Decreasing Postoperative Blood Loss by Topical vs. Intravenous Tranexamic Acid in Open Cardiac Surgery Phase 3
Recruiting NCT05945680 - Tranexamic Acid in Breast Esthetic Surgery. Phase 4
Recruiting NCT03783182 - Betamethasone (Betapred®) as Premedication for Reducing Postoperative Vomiting and Pain After Tonsillectomy Phase 4
Not yet recruiting NCT05464394 - Peroperative Administration of Tranexamic Acid in Roux-en-Y Gastric Bypass and One-anastomosis Gastric Bypass Phase 3